QIAGEN TAIWAN COMPANY LIMITED
- Address
- 臺北市中正區羅斯福路2段100號5樓
- Authorization Code
- 53326723
- Risk Class
- Class 2
- Manufacturer
- STAT Dx Life S.L;; QIAGEN GMBH
- Risk Class
- Class 2
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 3
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 2
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 3
- Manufacturer
- QIAGEN GMBH
- Risk Class
- Class 2
- Manufacturer
- SENTINEL CH. S.p.A.
- Risk Class
- Class 3
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 3
- Manufacturer
- QIAGEN GMBH
- Risk Class
- Class 1
- Manufacturer
- Plexus Manufacturing Sdn. Bhd.;; QIAGEN GMBH
- Risk Class
- Class 1
- Manufacturer
- SENTINEL CH. S.p.A.
- Risk Class
- Class 1
- Manufacturer
- SENTINEL CH. S.p.A.
- Risk Class
- Class 2
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 1
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 1
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 1
- Manufacturer
- NeuMoDx Molecular, Inc.
- Risk Class
- Class 1
- Manufacturer
- QIAGEN GMBH
- Risk Class
- Class 1
- Manufacturer
- QIAGEN GMBH;; Zollner Electronics GmbH
- Risk Class
- Class 1
- Manufacturer
- DYNEX TECHNOLOGIES INC.
- Risk Class
- Class 1
- Manufacturer
- QIAGEN
- Risk Class
- Class 2
- Manufacturer
- LRE MEDICAL GMBH;; QIAGEN GMBH
Explore comprehensive authorized representative profile for QIAGEN TAIWAN COMPANY LIMITED through Pure Global AI's free Taiwan medical device database. This authorized representative handles 20 product registrations across 9 manufacturers and 20 unique product types. Their regulatory history spans from Jun 29, 2021 to Mar 14, 2024.
This page provides detailed insights including 5 recent product registrations, 5 most popular products with "Kaijie" is a nucleic acid test group for brain inflammation/encephalitis pathogens having 1 registrations, and 5 represented manufacturers including NeuMoDx Molecular, Inc.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.